Inovio Pharmaceuticals Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Inovio Pharmaceuticals Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- INO
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001055726
Board of directors
-
Ann Calby Miller ยท DirectorSince 2023
-
David B. Weiner ยท DirectorSince 2023
-
Jacqueline Elizabeth Shea ยท Director ยท Chief Executive OfficerSince 2023
-
Jay Shepard ยท DirectorSince 2023
-
Lota S. Zoth ยท DirectorSince 2023
-
Roger D. Dansey ยท DirectorSince 2023
-
Simon X. Benito ยท DirectorSince 2023
-
Wendy L. Yarno ยท DirectorSince 2023
Chief executives
Jacqueline Elizabeth Shea
ยท Chief Executive Officer
Dates unknown
Board connections
3 of this board's directors also sit on 5 other boards.
- via Wendy L. Yarno
- via Wendy L. Yarno
- via Jay Shepard
- via Wendy L. Yarno
- via Lota S. Zoth
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 26, 2025 | Humeau Laurent Officer (Chief Scientific Officer) | Option exercise | +3,855 | โ | โ |
| Feb 26, 2025 | Sumner Michael John Officer (Chief Medical Officer) | Option exercise | +5,010 | โ | โ |
| Feb 26, 2025 | Jacqueline Elizabeth Shea Director, Officer (Chief Executive Officer) | Option exercise | +5,852 | โ | โ |
| Feb 26, 2025 | KIES PETER Officer (CFO) | Option exercise | +3,997 | โ | โ |
| Feb 26, 2025 | David B. Weiner Director | Option exercise | +972 | โ | โ |
| Feb 26, 2025 | Humeau Laurent Officer (Chief Scientific Officer) | Shares withheld for tax | โ1,584 | $1.98 | $3,136 |
| Feb 26, 2025 | Jacqueline Elizabeth Shea Director, Officer (Chief Executive Officer) | Shares withheld for tax | โ2,493 | $1.98 | $4,936 |
| Feb 26, 2025 | KIES PETER Officer (CFO) | Shares withheld for tax | โ2,362 | $1.98 | $4,677 |
| Feb 26, 2025 | David B. Weiner Director | Option exercise | +972 | โ | โ |
| Feb 26, 2025 | Humeau Laurent Officer (Chief Scientific Officer) | Option exercise | +5,010 | โ | โ |
| Feb 26, 2025 | Jacqueline Elizabeth Shea Director, Officer (Chief Executive Officer) | Option exercise | +18,632 | โ | โ |
| Feb 26, 2025 | KIES PETER Officer (CFO) | Option exercise | +5,010 | โ | โ |
| Feb 26, 2025 | Humeau Laurent Officer (Chief Scientific Officer) | Shares withheld for tax | โ2,059 | $1.98 | $4,077 |
| Feb 26, 2025 | Jacqueline Elizabeth Shea Director, Officer (Chief Executive Officer) | Shares withheld for tax | โ9,088 | $1.98 | $17,994 |
| Feb 26, 2025 | KIES PETER Officer (CFO) | Shares withheld for tax | โ2,960 | $1.98 | $5,861 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.